The future of women’s health: A new era of innovation and care
Women’s health has long been underfunded, understudied, and overlooked, but that’s slowly beginning to change. Femtech is helping to close critical care gaps and reshape how we think about everything from fertility to contraception to menopause.

Whether it’s a cycle-tracking app or an at-home hormone test, Femtech tools are giving women more insight into their health at every stage of life. These innovations are helping with earlier detection of conditions like PCOS, cervical cancer, and endometriosis, while also improving access to fertility care, menopause support, and sexual wellness -- areas that have often been dismissed or ignored in mainstream healthcare. With the help of connected devices, smart data, and AI, women are increasingly able to take a more active role in their care.
But this isn’t just about technology. It’s also about challenging outdated ideas about women’s health. For decades, many of the conditions women face have been under-researched or brushed off. Femtech is helping shift that narrative by putting women’s needs at the center, and advocating for care that’s inclusive, preventative, modernized, and even personalized.

Still, there’s a long way to go. Regulatory pathways are often unclear. Funding is still disproportionately low for women-led health startups. And there’s a major gap in research, especially when it comes to sex-specific data. Clinical trials should include a greater representation of women, and regulatory bodies should provide clearer guidelines for reviewing the types of products that Femtech companies are developing. At the same time, investment needs to catch up -- not just from venture capitalists, but also through grants, accelerators, and government support aimed at both academia and industry.

Femtech isn’t just about new gadgets or apps, it’s about advancing medical technologies that directly address women’s health needs, many of which have been historically overlooked. From non-surgical contraception to improved diagnostics and fertility solutions, these innovations are redefining what’s possible in care delivery. Emerging technologies like AI further enhance this progress by enabling more precise, personalized, and scalable solutions. With the right investment and support, Femtech can help establish a new standard of care, one that is scientifically rigorous, technologically advanced, and finally designed with women at the center.

About the author: Kathy Lee-Sepsick is CEO and founder of Femasys, a leading biomedical innovator addressing significant unmet needs in women’s health worldwide.

Back to HCB News

Business Affairs Homepage